Medical XpressStronger Cholesterol Treatment Shrinks More Plaque in Heart Arteries, New Clinical Trial Finds

⚠️ Small Study / Early Comparative Evidence

FLOWPROMOTE randomized 104 statin-naive adults in Denmark with stable chest pain and significant coronary artery disease to atorvastatin 40 mg or rosuvastatin 40 mg plus ezetimibe 10 mg daily. Coronary CT angiography assessed plaque at baseline, nine months, and 18 months. Combination therapy produced greater LDL-C lowering and total plaque regression. The findings extend imaging evidence for intensive lipid lowering, but the supplied report does not establish an incremental cardiovascular event benefit.

Clinical Considerations

• Total plaque volume fell 21.1% versus 13.6% with combination therapy and atorvastatin, respectively; these are relative changes in plaque volume.
• LDL-C fell 65% versus 38%. The combination group reached a reported average LDL-C of 42.5 mg/dL.
• Noncalcified plaque declined 28.2% versus 20%; regression occurred in 51 of 52 combination-treated participants versus 39 receiving atorvastatin.
• Both groups received high-intensity statin therapy. The comparison changed the statin and added ezetimibe, preventing isolation of ezetimibe’s contribution.
• Calcified plaque increased modestly in both groups. The report interprets this as stabilization, but calcification changes alone do not prove reduced event risk.
• The small, statin-naive population limits generalizability. The supplied report lacks detailed safety findings, confidence intervals, and follow-up completeness.

Practice Applications

• Recognize the greater imaging response without equating plaque regression with proven incremental protection against myocardial infarction, stroke, or death.
• Interpret the results as a comparison of two regimens, not proof that adding ezetimibe alone accounts for the difference.
• Discuss plaque regression as a possible treatment response while keeping lipid decisions grounded in established guidance, individual risk, achieved LDL-C, and tolerability.